Aurobindo Pharma plans to launch 50-60 products in US in FY21

▴ aurobindo-pharma-launch-5060-products-us-fy21
Aurobindo Pharma’s US business published a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20

Aurobindo Pharma is foreseen to launch 50 to 60 new products during the current year, notified N Govindarajan, MD of the company.

“We are expecting to launch around 50 to 60 products this year including injectables…Out of the 50 to 60 products that we are talking about, 25 products have already been approved,” he said during the latest earnings call earlier this month.

Aurobindo Pharma’s US business published a growth of 27 percent year-on-year to Rs 11,484 crore in FY20.

On a constant currency basis, it boosted by 26 percent year-after-year to around $1.62 billion led by development in volumes and new product launches.

The company has obtained final approval for six ANDAs and inaugurated four products in the fourth quarter of last fiscal.

For the full year, it has collected approval for 22 ANDAs and introduced 34 products across oral, injectable, and OTC segments, Govindarajan said.

Answering a query, he said that the company is scheduling to spend $150 to $200 million on capex in the current year.

Reports said that Aurobindo has spent Rs 958 crores towards research and growth in FY 20 which was 4.1 percent of its total revenues.

Govindarajan said the R&D expenditure would be 5.5 percent of the revenues for the current year.

Tags : #AurobindoPharma #USFDA

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma DreamFebruary 27, 2025
A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage SurgeryFebruary 27, 2025
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItFebruary 27, 2025
Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks SoFebruary 26, 2025
The Inequality of Survival: Why Some Women Die While Others LiveFebruary 26, 2025
The Corporate Invasion of Indian Hospitals: What It Means for YouFebruary 26, 2025
5 Simple Daily Habits to Keep Your Joints Healthy and Pain-FreeFebruary 25, 2025
Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in IndiaFebruary 25, 2025
With only 70 months left to end AIDS why is the urgency missing?February 25, 2025
Drenched in Oil: Is India Cooking Its Way to an Obesity Epidemic?February 25, 2025
Transforming Education: How Online Learning Platforms are Reshaping Study Material for Board and Competitive ExamsFebruary 24, 2025
February 24, 2025
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaFebruary 24, 2025
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemFebruary 24, 2025
From Science Fiction to Reality: AI Now Detects Blindness Before It StartsFebruary 24, 2025
Will India’s Healthcare Budget Support a Future of Robotic Surgeries?February 22, 2025
Is the World on the Brink of Another Pandemic? Scientists Discover a New Bat VirusFebruary 22, 2025
Newcastle University Expands Academic and Research Collaborations in IndiaFebruary 21, 2025
Get Ready to #BibaUp! Kriti Sanon Unveils the Season’s Most Stylish Summer CollectionFebruary 21, 2025
A Rare Condition: Surgery Saves 2-Day-Old Baby as Organs Shift Into ChestFebruary 21, 2025